Tizanidine Hydrochloride Capsule
Product Images NDC 76420-902

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tizanidine Hydrochloride (NDC 76420-902). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tiz01 (Tiz01)

FDA Label Image

Tiz02 (Tiz02)

FDA Label Image

Tiz03 (Tiz03)

This text appears to be a table displaying the improvement in Ashworth Score over time post-dose for different doses of tizanidine and a placebo. The table includes data for 16 mg tizanidine, 8 mg tizanidine, and a placebo at different time intervals.*

FDA Label Image

Tiz04 (Tiz04)

This text discusses the improvement in Ashworth Score using tizanidine at a mean dose of 26.8 mg. It mentions the end of the titration, end of maintenance, and the endpoint observed during the study.*

FDA Label Image

Label (Tizanidine Hydrochloride 2mg)

FDA Label Image

Label (Tizanidine Hydrochloride 4mg)

FDA Label Image

Label (Tizanidine Hydrochloride 6mg)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.